Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
575 INR | +0.64% | -5.54% | +14.00% |
14/05 | GRIFOLS SHARES DOWN 4.8% AFTER GOTHAM CITY RESEARCH ISSUES REPOR… | RE |
13/05 | Aarti Pharmalabs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 2,042
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical and Related Products
100.0
%
| - | - | 19,452 | 100.0 % | - |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 0 | nan % | 19,452 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 17/22/17 | |
Hetal Gogri Gala
CEO | Chief Executive Officer | 48 | 17/22/17 |
Piyush Lakhani
DFI | Director of Finance/CFO | - | 17/22/17 |
Nikhil Natu
CMP | Compliance Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hetal Gogri Gala
CEO | Chief Executive Officer | 48 | 17/22/17 |
Chairman | 49 | 07/21/07 | |
Director/Board Member | 77 | - | |
Director/Board Member | 64 | - | |
Director/Board Member | 75 | - | |
Director/Board Member | 63 | - | |
Director/Board Member | 56 | - | |
Director/Board Member | 67 | - | |
Director/Board Member | - | - | |
Chief Executive Officer | 59 | 17/22/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,626,008 | 47,193,340 ( 52.07 %) | 0 | 52.07 % |
Company contact information
Aarti Pharmalabs Ltd.
Embassy Park 247 LBS Marg, Vikhroli West
400083, Mumbai
+91 22 6797 6666
http://www.aartipharmalabs.comSector
1st Jan change | Capi. | |
---|---|---|
+14.00% | 622M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- AARTIPHARM Stock
- Company Aarti Pharmalabs Limited